BNF 6 Endocrine

Formulary	Last Updated
Endocrine System	May 2026

Prescribing Guidelines for BNF 6 Endocrine

Prescribing Guideline	Last Updated	Review Date
Cinacalcet prescribing and monitoring	April 2025	March 2028
Diabetes - Blood glucose and ketone meters, testing strips and lancets formulary	June 2023	May 2026
Diabetes - JAPC briefing for FreeStyle Libre/Dexcom ONE	April 2019	December 2023
Diabetes (Type 2 - management in adults)	December 2022	December 2025
Diabetes Glucose Monitoring - interim position statement	April 2022	March 2025
Diabetes Type 2 - Joint DLN Holding Statement for NICE NG28	March 2026	None
Fezolinetant Pathway	September 2026	August 2027
Finerenone prescribing guidance for primary care	March 2025	March 2028
Liothyronine Referral Guideline	March 2026	February 2029
Menopause - local management guideline	September 2025	August 2028
Osteoporosis - bisphosphonate treatment break	August 2026	July 2029
Osteoporosis - diagnosis & management	June 2025	May 2028
Tirzepatide - Management of overweight and obesity in primary care	August 2026	August 2027

Other Information

Relevant resources:

• Transgender and Non-Binary Adults - NHSE Service Specification- appendix J Arrangements for prescribing endocrine treatments (p.30-31)
• Trans healthcare - Advice based on GMC guidance
• Transgender Prescribing - Knowledge NoW : Resources produced by Norfolk and Waveney ICB to support primary care clinicians
• Gender incongruence in primary care - Advice from BMA
• Shared Care Agreements with unregulated providers for children and young people with gender incongruence - NHSE guidance
• Nottingham Centre for Transgender Health - Information including hormone therapy treatment 
• New Government restrictions on use of Puberty Suppressing Hormones (Puberty Blockers); Information for prescribers and pharmacists/dispensing doctors
• Biosimilar FAQ document: Nottinghamshire have produced a useful document to inform patients and clinicians about insulin and other biosimilars now available in primary care.
• Implementing the steroid card safety advice - PrescQIPP resource
• Supporting safe use of adrenal crisis emergency management kits - SPS
• NHS Type II Diabetes Path to Remission Programme - Referrer information
• GLP-1 agonists and contraception - Patient information leaflet
• Use of GLP-1 (incretin-based therapies) in women using hormone replacement therapy (HRT) - BMS advice